Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.
View/ Open
Date
2020-07ICR Author
Author
Cook, G
John Ashcroft, A
Pratt, G
Popat, R
Ramasamy, K
Kaiser, M
Jenner, M
Henshaw, S
Hall, R
Sive, J
Stern, S
Streetly, M
Bygrave, C
Soutar, R
Rabin, N
Jackson, GH
United Kingdom Myeloma Forum
Type
Other
Metadata
Show full item recordCollections
Subject
United Kingdom Myeloma Forum
Humans
Pneumonia, Viral
Coronavirus Infections
Multiple Myeloma
Recurrence
Antineoplastic Agents
Adult
Aged
Middle Aged
Female
Male
Clinical Audit
Pandemics
United Kingdom
Betacoronavirus
COVID-19
SARS-CoV-2
Research team
Myeloma Group
Language
eng
License start date
2020-07
Citation
British journal of haematology, 2020, 190 (2), pp. e83 - e86